Starting estrogen as a trans woman involves a few key steps: finding a prescribing provider, completing baseline bloodwork, and choosing a method of estrogen delivery that fits your body and lifestyle. The process can take anywhere from a single appointment to several months depending on how you access care. Here’s what to expect at each stage.
Two Paths to Getting a Prescription
There are two main models for accessing feminizing hormone therapy, and which one you encounter depends on where you live and which provider you see.
The informed consent model is the most common approach in the United States today. A prescribing clinician (often a primary care doctor, endocrinologist, or nurse practitioner) discusses the risks, benefits, and alternatives of hormone therapy with you directly. You give verbal or written consent, and the provider can prescribe estrogen without requiring a separate mental health evaluation. Many Planned Parenthood locations, LGBTQ health centers, and telehealth services operate this way. Some people receive a prescription at their first or second visit.
The mental health assessment model is the older approach and still required in some regions and by some providers. Under this model, a mental health clinician evaluates your history of gender identity, screens for co-occurring conditions, and writes a referral letter. This can add weeks or months depending on appointment availability. Current international guidelines note that requiring a mental health assessment can function as a barrier to care for adults, and the most recent standards no longer mandate it.
Both paths lead to the same medications. If you’re unsure where to start, searching for “informed consent HRT” plus your city or state will surface local options. Many trans community directories maintain updated lists of prescribers.
What Happens at Your First Appointments
Before prescribing estrogen, your provider will order baseline bloodwork. This typically includes a complete blood count, a comprehensive metabolic panel (which covers liver and kidney function), fasting lipids, hemoglobin A1c (a measure of blood sugar), and baseline levels of estradiol and total testosterone. These results give your provider a starting picture of your health so they can track changes and catch problems early.
Your provider will also review your medical history, paying attention to anything that could affect how safely you tolerate estrogen, particularly a personal or family history of blood clots, liver disease, or certain cancers. They’ll discuss the effects of hormone therapy on fertility, since estrogen suppresses sperm production and the timeline for that suppression varies. If biological children are something you want in the future, banking sperm before starting is strongly recommended. The full cycle of sperm development takes about three months, so samples collected while on estrogen tend to show abnormal quality. Research suggests that stopping hormones for at least three months can allow sperm quality to recover, but there’s no guarantee, and the longer you’ve been on therapy the less certain recovery becomes.
Choosing a Form of Estrogen
Estradiol, the primary estrogen used in feminizing therapy, comes in several forms. Each reaches similar target levels when dosed appropriately, but they differ in convenience, cost, and how they move through your body.
- Oral (pills): Typically started at 2 mg per day. Easy to take and widely available. Oral estradiol passes through your liver before entering your bloodstream, which is why providers monitor liver function. Some people take the pill sublingually (under the tongue) to partially bypass the liver, though this produces more variable blood levels.
- Transdermal (patches): Usually started at 50 to 100 micrograms per day, changed once or twice a week depending on the brand. Patches deliver estradiol directly into the bloodstream without a first pass through the liver, which gives them a lower risk profile for blood clots. Different patch brands can produce different estradiol levels even at the same stated dose, so blood work matters. Skin irritation at the patch site is the most common complaint.
- Injectable: Estradiol valerate or cypionate, often started around 1 mg per week, injected into muscle or under the skin. Injections tend to produce higher peak levels followed by a trough before the next dose, so your provider will want blood drawn at the midpoint between injections to get an accurate reading. Many people prefer injections because they don’t require daily attention, though learning to self-inject takes a short adjustment period.
Your provider will typically start at a low dose and increase gradually over several months, guided by your blood levels and how you’re responding. The target ranges most providers aim for are estradiol between 100 and 200 pg/mL and testosterone below 50 ng/dL, consistent with Endocrine Society and WPATH guidelines.
Anti-Androgens and Why They’re Used
Estrogen alone can suppress testosterone significantly, but many providers prescribe an anti-androgen alongside it, especially early on when estrogen doses are still being ramped up. The most common option in the U.S. is spironolactone, typically dosed around 100 mg per day. Spironolactone blocks testosterone from binding to its receptors and has the side effect of making you urinate more frequently, so staying hydrated matters. Because it affects potassium levels, your provider will monitor your electrolytes through routine blood work.
Outside the U.S., cyproterone acetate is widely used at low doses (often 12.5 mg per day or less). It directly suppresses testosterone production and is quite effective, but it’s not available in the United States and carries risks to the liver at higher doses. Some providers use other approaches, including GnRH agonists that shut down testosterone production at the hormonal source, or progesterone, though evidence on progesterone’s role in feminization is still limited.
Not everyone needs an anti-androgen long term. Once estrogen reaches therapeutic levels, testosterone often drops into the target range on its own, and some people taper off their blocker entirely.
What Changes to Expect and When
Feminizing hormone therapy produces gradual changes over months and years, not days. Knowing the general timeline helps set realistic expectations.
Breast development is one of the first noticeable changes, beginning around 3 to 6 months after starting. You’ll likely feel tenderness or budding before visible growth. Full breast development takes 2 to 3 years, though genetics play a significant role in final size, just as they do for cisgender women.
Skin becomes softer and less oily within the first 3 to 6 months, which is also when most people notice their scent changing. Body fat starts redistributing in that same window, gradually shifting toward the hips, thighs, and buttocks over the course of 2 to 5 years. This redistribution is slow and works best in combination with overall body composition. Facial changes come primarily from fat redistribution and are subtle but cumulative.
Body hair growth slows and the hair itself becomes finer, though estrogen won’t eliminate existing terminal hair (the thick, dark kind). Many trans women pursue laser hair removal or electrolysis for facial hair separately. Scalp hair may improve modestly if you’ve experienced androgenic hair loss, though results vary widely.
Emotional changes are harder to put on a timeline but are commonly reported within the first few months. Many people describe a broader emotional range, easier access to tears, and shifts in libido. Spontaneous erections decrease, and testicular volume gradually shrinks.
Ongoing Monitoring
After starting, your provider will check blood levels at regular intervals, typically every 3 months during the first year. Follow-up labs usually include estradiol, total testosterone, a complete blood count, and a comprehensive metabolic panel. Lipid panels and A1c are checked periodically based on standard screening guidelines rather than at every visit.
These check-ins are where dosage adjustments happen. If your estradiol is below the target range, your dose goes up. If your testosterone isn’t suppressing adequately, your provider might increase estrogen, adjust your anti-androgen, or switch delivery methods. The goal is to find a stable regimen that keeps your levels in range with minimal side effects.
Blood Clot Risk in Context
The most commonly discussed medical risk of feminizing hormone therapy is venous thromboembolism, or blood clots. This risk was significantly higher with older synthetic estrogens, particularly ethinyl estradiol, which is no longer recommended for hormone therapy. Modern bioidentical estradiol (the kind prescribed today) carries a much lower risk. Transdermal estrogen in particular has shown a low clot-forming profile in both trans women and postmenopausal cisgender women, making it the preferred option for anyone with additional clot risk factors like smoking, obesity, a clotting disorder, or age over 40.
Your provider will assess your individual risk factors at baseline. For most healthy adults starting at standard doses, the absolute risk of a clot remains small, but it’s not zero. Knowing the warning signs of a deep vein thrombosis (sudden swelling, pain, or warmth in one leg) or pulmonary embolism (sudden shortness of breath, chest pain) is worth keeping in the back of your mind.